Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England
Kieran J Rothnie,1 Sandra Joksaite,1 Leah B Sansbury,2 Chris Compton,3 Valentina Di Boscio,4 Afisi S Ismaila5,6 1Value Evidence and Outcomes, R&D Global Medical, GlaxoSmithKline, London, UK; 2Value Evidence and Outcomes, R&D Global Medical, GlaxoSmithKline, Research Triangle Park, NC, USA; 3...
Main Authors: | Rothnie KJ, Joksaite S, Sansbury LB, Compton C, Di Boscio V, Ismaila AS |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-06-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/characteristics-of-new-users-of-single--and-multiple-inhaler-triple-th-peer-reviewed-fulltext-article-COPD |
Similar Items
-
Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial
by: Paly VF, et al.
Published: (2022-12-01) -
Quantifying the Economic Impact of Delayed Multiple-Inhaler Triple Therapy Initiation in Patients with COPD: A Retrospective Cohort Study of Linked Electronic Medical Record and Hospital Administrative Data in England
by: Sansbury LB, et al.
Published: (2021-10-01) -
Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States
by: Bogart M, et al.
Published: (2024-01-01) -
Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region
by: Emanuela Resta, et al.
Published: (2022-10-01) -
Comparison of treatment persistence, adherence, and risk of exacerbation in patients with COPD treated with single-inhaler versus multiple-inhaler triple therapy: A prospective observational study in China
by: Ling Lin, et al.
Published: (2023-03-01)